Collegium Pharmaceutical Inc. (COLL)
NASDAQ · Healthcare
Collegium Pharmaceutical Inc. EBITDA 2016–2025
Collegium Pharmaceutical Inc. annual/quarterly ebitda history and growth rate from 2016 to 2020. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- Collegium Pharmaceutical Inc. ebitda for the quarter ending March 31, 2020 was 5.3 M, a 153.62% decrease year-over-year.
- Collegium Pharmaceutical Inc. ebitda for the twelve months ending March 31, 2020 was -40.2 M.
- Collegium Pharmaceutical Inc. annual ebitda for 2019 was -23.0 M, a 17.37% increase from 2018.
- Collegium Pharmaceutical Inc. annual ebitda for 2018 was -19.6 M, a 73.80% decrease from 2017.
- Collegium Pharmaceutical Inc. annual ebitda for 2017 was -74.9 M, a 19.88% decrease from 2016.
- Collegium Pharmaceutical Inc. annual ebitda for 2016 was -93.4 M.
EBITDA
TRAILING 12 MONTHS · $B
QUARTERLY · $B
Collegium Pharmaceutical Inc. EBITDA — FAQ
Collegium Pharmaceutical Inc. (COLL) ebitda over the last 10 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see COLL's ebitda history?
The chart and table above show Collegium Pharmaceutical Inc.'s ebitda by year and by quarter, including the growth rate.